Active · per the CBE, 16 November 2026

Asahi Kasei Bioprocess Europe

BE0480190679

Rechtspersoon Public limited company 1 establishment

Asahi Kasei Bioprocess Europe is a market research agency in Schaarbeek. Public Limited, started on 9 May 2003, 1 establishment.

Auguste Reyerslaan 70, 1030 Schaarbeek

Active for

23 year, 6 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 55 % of short-term debt in 2026; threshold 65 %.

  • Busy address KBO

    50 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2026

Asahi Kasei Bioprocess Europe from Schaarbeek, company number BE0480190679, closed financial year 2026 with a result of € 8.7 million after tax. For that financial year Asahi Kasei Bioprocess Europe recorded revenue of € 136.2 million and equity of € 9.3 million. Compared with financial year 2025, the result moved from € 6 million to € 8.7 million. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 12, 2026.

What it is worth Growing

€ 9.3 million

▲ 23% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8.7 million

▲ 46% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 15.2 million

▲ 16% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 7 million paid out

80 % of the profit went to the shareholders, mostly to Asahi Kasei Life Science Corporation (100 % of the shares). That is where the money ends up.

People and assets in 2026

Full-time equivalents

16.8

▼ 0.1 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 4.2 million

▲ 5% vs 2025

€ 250,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 464,057

▼ 16% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 58.4 million

▲ 9% vs 2025

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 177 days on average.

Taxes and wages

€ 976,143

▲ 22% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
2023202420252026Change 2025 → 2026
Revenue € 135,659,221 € 121,958,665 € 125,565,322 € 136,188,970 ▲ 8%
Profit after taxes € 8,351,028 € 4,971,074 € 5,978,520 € 8,743,367 ▲ 46%
Equity € 16,604,815 € 13,575,888 € 7,554,408 € 9,297,775 ▲ 23%
Total debts € 77,652,957 € 60,170,979 € 66,342,554 € 66,388,242
Cash € 28,507,099 € 9,317,616 € 13,122,343 € 15,241,700 ▲ 16%
Retained profit € 16,104,815 € 13,075,888 € 7,054,408 € 8,797,775 ▲ 25%
Dividend € 0 € 8,000,000 € 12,000,000 € 7,000,000 ▼ 42%
Balance sheet total € 94,270,012 € 73,746,868 € 73,950,982 € 75,686,017 ▲ 2%
Employees (FTE) 16 16.3 16.9 16.8 ▼ 0.1

By revenue, Asahi Kasei Bioprocess Europe ranks 1st of 4 companies with main activity “Markt- en opinieonderzoek” in Schaarbeek that publish figures (fiscal year 2026).

Key figures of Asahi Kasei Bioprocess Europe, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Asahi Kasei Bioprocess Europe?

What happened at Asahi Kasei Bioprocess Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Yutaka Yoshimoto stepped down as director. NBB
  • Atsuo Kubota stepped down as director. NBB
  • New annual accounts for financial year 2026: profit of € 8.7 million (▲ 46% vs 2025). Source: NBB ↗
  • Yutaka Yoshimoto became a director. NBB
  • Yusuke Kanazawa stepped down as director. NBB
  • Masahi Yamamoto stepped down as director. NBB
  • Atsuo Kubota became a director. NBB
  • Yusuke Kanazawa became a director. NBB

In short

From € 8.4 million profit in 2023 to € 8.7 million profit in 2026.

Paid € 9.7 million in corporate taxes since 2023.

Best year ever: 2026, with € 8.7 million profit.

Paid out € 27 million in dividends to the owners in total.

Management

Asahi Kasei Life Science Corporation 100%
Asahi Kasei Bioprocess Europe

The shares are held by Asahi Kasei Life Science Corporation (100%).

Directors

According to the 2026 annual accounts

Yutaka Yoshimoto

Director

since 2026 · until 2032

Yusuke Kanazawa

Director

since 2023 · until 2026

Atsuo Kubota

Director

since 2024 · until 2030

Masahi Yamamoto

Director

since 2021 · until 2026

Shareholders

Asahi Kasei Life Science Corporation

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Auguste Reyerslaan 70

1030 Schaarbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Schaarbeek

Same main activity (Markt- en opinieonderzoek), 30 active companies in Schaarbeek, largest first.

Centre d'Information sur les Media

€ 12.9 million revenue · 2025

BERRY BE RESEARCH

€ 772,666 gross margin · 2025

I.C. BELGIUM

€ 589,444 gross margin · 2024

INTERGEST BELGIUM

€ 573,293 gross margin · 2025

ASSOCIATION POUR UNE FONDATION TRAVAIL-UNIVERSITE

€ 521,943 gross margin · 2025

THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM

€ 456,794 gross margin · 2025

Details

Company number
0480.190.679
VAT number
BE 0480.190.679
Registered office
Auguste Reyerslaan 70, 1030 Schaarbeek
Names & denominations
Asahi Kasei Bioprocess Europe
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
9 May 2003
Peppol
Active · Active since 29 Nov 2025
Activities · NACE

Markt- en opinieonderzoek

Marktonderzoekbureaus

Groothandel in farmaceutische en medische artikelen

Overige technische testen en toetsen

Overige detailhandel in nieuwe artikelen neg

Overige gespecialiseerde detailhandel in artikelen, andere dan voedingsmiddelen, n.e.g.

Technische testen en analyses

Frequently asked questions

What does Asahi Kasei Bioprocess Europe do?
Asahi Kasei Bioprocess Europe is a market research agency in Schaarbeek. Public Limited, started on 9 May 2003, 1 establishment.
What is the address of Asahi Kasei Bioprocess Europe?
The registered office of Asahi Kasei Bioprocess Europe is located at Auguste Reyerslaan 70, 1030 Schaarbeek.
Is Asahi Kasei Bioprocess Europe still active?
Yes. According to the CBE (16 November 2026) Asahi Kasei Bioprocess Europe is active, legal situation “Normale toestand”, started on 9 May 2003.
Is Asahi Kasei Bioprocess Europe registered on Peppol?
Yes, Asahi Kasei Bioprocess Europe is registered on the Peppol network with ID 0208:0480190679.
What is the enterprise number of Asahi Kasei Bioprocess Europe?
The enterprise number of Asahi Kasei Bioprocess Europe is BE0480190679.
When was Asahi Kasei Bioprocess Europe founded?
Asahi Kasei Bioprocess Europe was founded on 9 May 2003.